Ballerup, Capital Region of Denmark, DK (On-site)1 open job
Novo Nordisk is a global healthcare company that discovers, develops, manufactures and delivers treatments for chronic diseases including diabetes, obesity, haemophilia, growth disorders and cardiovascular conditions.
Novo Nordisk is a global pharmaceutical company that discovers, develops, manufactures, and delivers treatments for serious chronic diseases - diabetes, obesity, haemophilia, growth disorders, and cardiovascular conditions. Founded in 1923 and headquartered in Denmark, the company reports roughly 67,000 employees, affiliates in 80 countries, and medicines reaching more than 46.5 million people worldwide. CEO is Maziar Mike Doustdar.
The operating footprint is wide and physically distributed: production sites in Belgium, Brazil, China, France, Italy, and the United States, plus research and development facilities in China, the United States, the United Kingdom, and India. That spans biologics and medicine manufacturing, drug discovery, and research programs in endocrinology and metabolic disease, cardiovascular disease, and haematology - an estate that ties clinical research data, industrial production systems, and global distribution into one operational surface.
Technically, the work sits at the intersection of pharmaceutical R&D and large-scale healthcare delivery: drug discovery pipelines, chronic disease therapeutics, and the manufacturing and access programs that get treatments to patients. The stated culture signals emphasize an integrated model - discovery through delivery - combined with expanding access to treatments, and a mission framed around defeating serious chronic diseases. Any role here operates inside a century-old, highly regulated, multinational environment where the systems under management are research, production, and patient-facing at once.
